Health
Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2 – News-Medical.Net
A new study reports a very promising anti-SARS-CoV-2 monoclonal antibody, HB27, that appears to have two distinct mechanisms of action inhibiting the virus-host…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative pathogen of coronavirus disease 2019 (COVID-19) – has infected over 61.1 million people worldwide and caused over 1.43 million deaths.
As scientists continue to probe for effective pharmaceutical interventions against SARS-CoV-2, a new study reports a very promising monoclonal antibody, HB27, that appears to have two distinct mechanisms of action inhibiting the virus-host cell interaction and subsequent infection. This…
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General16 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase